New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic’s new vessel sealer, Quest’s brain infection test gain FDA market go-ahead.
You may also be interested in...
Medtronic Builds Surgical Device Offerings Via Salient, Peak Acquisitions
Medtronic will expand its energy-based surgical equipment offerings through its purchase of privately-held Salient Surgical Technologies and Peak Surgical under separate agreements valued at a combined $645 million, announced July 7.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.